These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30530834)

  • 1. The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.
    Andrikopoulos P; Kieswich J; Pacheco S; Nadarajah L; Harwood SM; O'Riordan CE; Thiemermann C; Yaqoob MM
    J Am Soc Nephrol; 2019 Jan; 30(1):33-49. PubMed ID: 30530834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis.
    Das R; Kim SJ; Nguyen NT; Kwon HJ; Cha SK; Park KS
    Kidney Int; 2019 Oct; 96(4):927-941. PubMed ID: 31377057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
    Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
    Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
    Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
    Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Inhibition by Trametinib Attenuates Systemic Inflammatory Responses and Multiple Organ Injury in Murine Sepsis.
    Smith JA; Mayeux PR; Schnellmann RG
    Crit Care Med; 2016 Aug; 44(8):e711-20. PubMed ID: 27031380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
    Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
    Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP1 inhibitor UK383,367 attenuates renal fibrosis and inflammation in CKD.
    Bai M; Lei J; Wang S; Ding D; Yu X; Guo Y; Chen S; Du Y; Li D; Zhang Y; Huang S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1430-F1438. PubMed ID: 31545926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trametinib and dactolisib but not regorafenib exert antiproliferative effects on rat pancreatic stellate cells.
    Witteck L; Jaster R
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):642-50. PubMed ID: 26663013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
    Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
    Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
    Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
    Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-β and EMT/Slug signalling.
    Annaldas S; Saifi MA; Khurana A; Godugu C
    Mol Immunol; 2019 Aug; 112():247-255. PubMed ID: 31202101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction.
    Mustafa M; Wang TN; Chen X; Gao B; Krepinsky JC
    Am J Physiol Renal Physiol; 2016 Sep; 311(3):F614-25. PubMed ID: 27385736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
    Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
    Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine Kinase-2 Deficiency Ameliorates Kidney Fibrosis by Up-Regulating Smad7 in a Mouse Model of Unilateral Ureteral Obstruction.
    Schwalm S; Beyer S; Frey H; Haceni R; Grammatikos G; Thomas D; Geisslinger G; Schaefer L; Huwiler A; Pfeilschifter J
    Am J Pathol; 2017 Nov; 187(11):2413-2429. PubMed ID: 28807595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
    Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
    Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking AURKA with MK-5108 attenuates renal fibrosis in chronic kidney disease.
    Jiang M; Bai M; Xu S; Wang T; Lei J; Xu M; Huang S; Jia Z; Zhang A
    Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166227. PubMed ID: 34311081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
    Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
    Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pomolic Acid Ameliorates Fibroblast Activation and Renal Interstitial Fibrosis through Inhibition of SMAD-STAT Signaling Pathways.
    Park JH; Jang KM; An HJ; Kim JY; Gwon MG; Gu H; Park B; Park KK
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30177595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
    Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
    Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.